Racing NSW Stewards conducted an inquiry into the Analysts’ findings of Tapentadol and Metformin in the post-race urine sample taken from UNO THAT after that gelding ran second in Race 3 (Wongawilli Provincial & Country Maiden Plate, 1300m) conducted at Kembla Grange racecourse on Tuesday, 5th February 2019.
Evidence was yesterday taken from trainer of Uno That, Peter Korn; Racing NSW Senior Veterinary Officer, Dr James Mizzi and ARFL Science Manager, Dr Adam Cawley.
The inquiry was unable to determine the cause for the detection of Tapentadol (human pain relief medication), however, the Stewards were satisfied that on balance the likely cause for the detection of Metformin was due to contamination via Mr Korn who was prescribed a medication containing Metformin.
Mr Korn pleaded guilty to a charge under AR240(2) of having presented Uno That to race at Kembla Grange Racecourse on Tuesday, 5th February 2019, and the post-race urine sample taken from Uno That was found to contain the prohibited substances Tapentadol and Metformin.
Having considered matters relevant to penalty, including Mr Korn’s excellent disciplinary record as a licenced trainer for approximately 50 years, he was fined the sum of $4000.
Mr Korn was advised of his right of appeal.
In accordance with the provisions of AR240(1), Uno That was disqualified from its second placing and accordingly the placings were amended as follows:
|04. Holy Reign||- 1st|
|06. Lord Desanimaux||- 2nd|
|10. War Cabinet||- 3rd|
|03. Big Data||- 4th|
|08. Psicopatico||- 5th|
|11. Milawa||- 6th|
|05. Kentucky Award||- 7th|
Division 2 – Prohibited substance in a sample taken from a horse
AR 240 Prohibited substance in sample taken from horse at race meeting